Abstract
| Poster Session I |
||
|---|---|---|
|
|
||
| P001 | Rik Ossenkoppele | Increased Parietal Amyloid Burden and Metabolic Dysfunction in Alzheimer's Disease with Early Onset |
| P003 | Hiroshi Ito | Effects of the Partial Agonist Antipsychotic on Dopamine Synthesis Capacity in Human Brain Measured by PET with [C-11]DOPA |
| P007 | Paul Stokes | History of Cigarette Smoking Associated with Increased Limbic GABAA Receptor Availability |
| P008 | Jun Maeda | Altered Serotonin Release and Serotonin 1A Receptor Density in CaMKIIα-Deficient Mice Assessed by a Comparison of In Vivo PET and In Vitro Autoradiographic Data |
| P010 | Hiroshi Kawaguchi | Comparison between Neuromelanin-Related MRI Signal and Dopamine Transporter Binding Measured by PET in Humans |
| P013 | Adriann Lammertsma | Flumazenil is a Weak Substrate for P-Glycoprotein in Humans: A PET Study in Pharmacoresistant Patients with Unilateral MTS |
| P014 | Oliver Howes | Mechanisms Linking Cannabis Use with Psychosis and Anxiety: Studies of the Dopaminergic and Cannabinoid Systems |
| P015 | Nicola J. Kalk | Affinity of Commonly-Prescribed Benzodiazepines for the 18 kDa Translocator Protein (TSPO): Implications for Imaging Studies |
| P017 | David Matuskey | Association between 5HT1B Receptors and Cocaine Dependence in Human Subjects |
| P018 | Osama Sabri | PET Imaging of Cerebral Nicotinic Acetylcholine Receptors (nAChRs) in Early Alzheimer's Disease (AD) Assessed with the New Radioligand (−)-[18F]-Norchloro-fluoro-homoepibatidine ([18F]Flubatine) |
| P021 | Masaki Tokunaga | Effects of NMDA Receptor Antagonists on the Binding of Agonistic and Antagonistic Radiotracers to Striatal Dopamine D2 Receptors |
| P022 | Nicholas Seneca | Anti-CD20 Therapy Reduces Lesion Volume and Activated Microglia in Rodent Models of Multiple Sclerosis |
| P030 | Sjoerd Finnema | Tiagabine Does Not Modify [11C]Ro 15-4513 and [11C]Flumazenil Binding to a Major Extent in Anesthetized Non-Human Primates |
| P033 | Withdrawn | |
| P034 | Kristina Fischer | In Vivo Quantification of Striatal Dopamine D2 Receptor Expression and [11C]Raclopride Affinity Using a Single Injection Protocol |
| P035 | Ingo Vernaleken | The Impact of Dopamine on Behaviour During an Aggression Provocation Paradigm: An [18F]FDOPA PET Study |
| P036 | Andrea Varrone | Preliminary Evaluation of the Quantification and Metabolism in Human Subjects of the Dopamine Transporter Radioligand [18F]FE-PE2I |
| P037 | Alexander Hammers | Periventricular Flumazenil Binding for Predicting Postoperative Outcome in Individual Patients with Temporal Lobe Epilepsy and Hippocampal Sclerosis |
| P041 | Miran Kenk | Whole Body Biodistribution and Radiation Dosimetry in Humans of a New PET Ligand, [18F]-FEPPA, to Image Translocator Protein (18kDa), and Influence of Genotype |
| P042 | David Erritzoe | In Vivo Imaging of Dopamine D3 Receptors in Alcoholism Using [11C]PHNO-PET, and a Selective D3 Receptor Antagonist |
| P043 | Jogesh Mukherjee | Norepinephrine Binds to 11CPIB Labeled β-Amyloid Plaques in Post-Mortem Alzheimer's Disease Brain |
| P047 | Cristian C. Constantinescu | Evaluation of D3 versus D2 Receptor Binding in Rats and D2R Knockout Mice Using In Vivo PET Imaging with [18F]Desmetoxyfallypride and [18F]Fallypride |
| P051 | Rupert Lanzenberger | Molecular Imaging Genetics of the Serotonin-IA Receptor Investigating the Common rs6295 Single Nucleotide Polymorphism |
| P054 | Anat Maoz | Disrupted Adenovirus-Based Anti-Cocaine Vaccine: Assessment of Efficacy Based on PET Dopamine Transporter (DAT) Imaging and Cocaine Challenge |
| P055 | Robert Kessler | Regional Dopamine Release and Dopamine D2 Receptor Levels in Normal Weight, Overweight and Mildly Obese Subjects |
| P057 | Jinbin Xu | Dopamine D1, D2 and D3 Receptor Densities in the Striatal and Extra-Striatal Regions of the Aged Healthy Human Brain |
| P058 | Doris J. Doudet | Evaluating NA Release with C-11 Yohimbine: Combined In Vivo PET-Microdialysis Studies |
| P061 | Albert Gjedde | Modulation of Brain Activity by DOPAergic Volume Transmission |
| P062 | Mary Blue | PET Imaging of D2 Receptor in Rett Syndrome and in Mecp2-Deficient Mice |
| P063 | Adjmal Nahimi | Chronic L-DOPA Treatment Prevents Increased Binding of [11C]MDL100907 to 5-HT2A Receptors in a Rat Model of Parkinson's Disease |
| P065 | Dean F. Wong | Dopamine Release and Serotonin Interactions in Tourette's Syndrome: New Relations to Obsessive Compulsive Disorder |
| P066 | Bedda Rosario | Voxel Level Concordance-Discordance Analysis of [11C]PiB and Florbetapir PET |
| P067 | Jenny-Ann Phan | Amphetamine-Induced Inhibition of [11C]Yohimbine Binding in Rat Brain |
|
|
||
| P070 | Sangram Nag | Synthesis and PET Evaluation of a Novel F-18 Labeled Deuterated Fluorodeprenyl ([18F]Fluorodeprenyl-D2) Radioligand to Study MAO-B Activity |
| P076 | Nahid Amini | Prediction and Identification of PET Radiometabolites by Cytochrome P450, UPLC/Q-ToF-MS and Fast Radio-LC: Application to [18F]FE-PE2I |
| P077 | Osama Sabri | Imaging of the Brain Serotonin Transporters (SERT) with a New Fluorine-18 Labelled Fluoromethyl-Analogue of McN5652 and PET in Humans |
| P079 | Anders Ettrup | Development of an 18F-Labelled 5-HT2A Receptor Agonist PET Radioligand |
| P080 | Ansel Hillmer | Determination of In Vivo Kinetic Properties of α4β2* nAChR Specific [18F]Nifene in the Nonhuman Primate |
| P081 | Jeffery Batis | In Vivo Assessment of [123I]MNI420, an Adenosine 2a SPECT Radioligand, in Nonhuman Primates |
| P082 | Patrick Riss | Synthesis, Radiolabelling and Validation of (20R)-4,5-α-epoxy-17-methyl-3-hydroxy-6-(2-[18F]fluoroethoxy)-α,17-dimethyl-α-(2-phenyleth-1-yl)-6,14-ethenomorphinan-7-methanol ([18F]FEPEO) |
| P091 | Eric Hostetler | Characterization of the Opioid Receptor-Like 1 (ORL1) PET Tracer [18F]MK-0911 in Rhesus Monkey and Human Brain |
| P094 | Su Jin Kim | In Vivo Selectivity of New Kappa Opioid Receptor Ligand [11C]LY2795050 in Rhesus Monkey |
| P097 | Hanne D. Hansen | In Vivo PET Imaging of Cerebral 5-HT7 Receptors with Novel Radioligands |
|
|
||
| P113 | Pablo Rusjan | Initial Evaluation of [11C]-CURB in Human Brain Using Positron Emission Tomography |
| P117 | Marjorie Gonzalez | Novel Spatial Analysis Method for PET Data Using 3D Moment Invariants: Applications to Parkinson's Disease |
| P119 | Marissa D. Zwan | Visual Assessment of Parametric [11C]PIB Images in a Memory Clinic Population |
| P134 | Mika Naganawa | In Vivo Evaluation of α7 Nicotinic Acetylcholine Receptors in Rhesus Monkey Brain with [11C]NS14492 |
| P139 | Aniket Joshi | Estimation of Total Volume of Distribution with Limited Blood Sampling: Application to mGluR5 Selective PET Tracer [18F]FPEB |
| P148 | Alexander Hammers | A Multi-Atlas Based Method for Automated Anatomical Rat Brain MRI Segmentation and Extraction of PET Kinetics |
| P151 | R. Todd Ogden | Kinetic Modeling without a Reference Region |
| P154 | Christin Y. Sander | Coupling of Neurovascular Response and Receptor Occupancy with Simultaneous PET/fMRI |
| P159 | Shuo Wang | Optimization of HYPR Filter for Detection of Smoking-Induced Dopamine Release in [11C]Raclopride PET Studies |
| P162 | Hyeyun Jung | VOI-based Evaluations of the Accuracy of Spatial Normalization and Existing Automated VOI Methods for Neuroimaging |
| P166 | Yun Zhou | Evaluation of Noninvasive Estimation of Distribution Volume and Distribution Volume Ratio Method for Unbiased Quantification of Multi-Center [11C]PiB Human Dynamic PET Studies |
| P167 | Ayon Nandi | Improving MicroPET Quantification: Semi-Automated Volumes of Interest |
| P168 | Iwao Kanno | Evaluation of Inter-Scanner Differences in Effect of Radioactivity from Outside FOV |
| P169 | Yasuyuki Kimura | Inter-Scanner Differences in Dopamine Receptor Imaging |
| P170 | Zheng Miao | Direct High Yield No-Carrier Added Radiosynthesis of [F-18]Catecholamines |
| Poster Session II |
||
|---|---|---|
|
|
||
| P002 | Rik Ossenkoppele | Differential Impact of Apolipoprotein E Genotype on Distributions of Amyloid Load and Glucose Metabolism in Alzheimer's Disease |
| P004 | Keisuke Takahata | Regional Distribution of Dopamine D2 Receptor Occupancy by Aripiprazole: A PET Study Using [11C]Raclopride and [11C]FLB457 |
| P012 | Paul Stokes | Nature or Nurture? Determining the Heritability of Human Dopamine Function: An [18F]-DOPA PET Study |
| P016 | Darren Quelch | The Effects of Different Cellular Environments on Opioid Receptor Binding |
| P019 | Henry Karlsson | Decreased μ-Opioid Receptor Binding in Brain Reward Circuitry in Morbid Obesity |
| P024 | Bart van Berckel | Dose Dependent Occupancy of Central Dopamine D2 Receptors by the Dopamine Stabilizer (−)-OSU6162 |
| P025 | Sjoerd Finnema | The Novel Dopamine D2/D3 Receptor Agonist Radioligand [18F]MCL-524 is Sensitive to Dopamine Levels |
| P038 | Maxime Parent | Quantification of Cholinergic Degeneration in Alzheimer's Disease Using [18F]Fluoroethoxybenzovesamicol Autoradiography |
| P040 | Markus Savli | Brodmann Area Database of the Serotonergic System in Healthy Subjects Using Multi-Tracer PET |
| P052 | Kazuhisa Tsuda | Preliminary Analysis of the Difference of Amyloid Beta Detectability by 11C-Pittsburgh Compound-B PET (PIB PET) in Different Image Display Conditions |
| P060 | James Robert Brašić | Effects of Amphetamine-Induced Dopamine Release and Raclopride-Induced Dopamine Blockade on Psychiatric Symptoms and Tics of Subjects with and without Gilles De La Tourette Syndrome |
|
|
||
| P068 | Dana Benesh | Identification of a Pre-Clinical In Vivo Receptor Occupancy Tracer Molecule for the MCH1 Receptor |
| P069 | Pieter Klein | GMOM Analogs for PET Imaging of the NMDA Receptor: Synthesis and Evaluation |
| P072 | Adriana A. S. Tavares | Radioiodinated Reboxetine Analogues for Imaging of the Norepinephrine Transporters in Brain Using Single Photon Emission Computed Tomography |
| P073 | Luca Gobbi | Characterization of the Radiotracers [3H]- and [11C]-RO6802488 for Imaging PDE10A |
| P074 | Andrei Postnov | Modelling of the Novel P-gp Expression Tracer [11C]Laniquidar: ATest-Retest Study in Healthy Volunteers |
| P075 | Teri Kreisl | [11C]N-Desmethyl-Loperamide as a Marker of Pgp Function in Patients with Gliomas |
| P084 | Andrea Varrone | PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Non-Human Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ |
| P086 | Shuiyu Lu | Labeling of Tubastatin A with Carbon-11 in the Hydroxamic Acid Carbonyl Position for PET Imaging of Histone Deacetylase 6 in Brain |
| P089 | Jogesh Mukherjee | Imaging Norepinephrine Transporter and Glucose Metabolism in Rat Brown Adipose Tissue |
| P090 | Olivier Barret | [18F]-MNI654 and [18F]-MNI659: Novel PET Imaging Tracers to Quantify PDE10A |
| P095 | Alexander Hammers | Quantification of Activated NMDA Receptors with [18F]GE-179 PET |
| P096 | Jamie Eberling | Consortium to Develop an Alpha-Synuclein Imaging Agent |
| P098 | Hanne D. Hansen | Optimized Bolus/Infusion Scheme and Determination of In Vivo Kd for [11C]AZ10419369 in Non-Human Primates |
|
|
||
| P099 | Irina Esterlis | Imaging the Sensitivity of [123I]5-IA-85380 to Increases in Acetylcholine at the Beta2-Nicotinic Acetylcholine Receptors: Physostigmine Studies in Human Subjects |
| P100 | Keisuke Matsubara | Correction for Radiolabeled O-Methyl Metabolite in Human Brain during L-[β-11C]DOPA PET |
| P102 | Masayuki Suzuki | Reproducibility of PET Studies with L-[β-11C]DOPA and [18F]FE-PE2I in Healthy Humans |
| P103 | Yoko Ikoma | Correction of Head Movement by Frame-to-Frame Image Realignment on Human Brain PET Images with [11C]Raclopride and [11C]FLB457 |
| P107 | Hiroyuki Ohba | Feedback-Controlled Bolus Plus Infusion (FC-B/I) Method for Quantitative Measurement of Receptor Binding with F-18-Labeled PET Ligand in Living Brain of Conscious Monkey |
| P109 | Andreas Hahn | Combining Image-Derived and Venous Input Functions for Serotonin-1A Receptor Quantification |
| P108 | Katarina Varnas | Evaluation of Two Methods for Automated PET Region of Interest Analysis |
| P110 | Paolo Zanotti- | Validation of Population-Based and Image-Derived Input Functions in the Tracer Kinetic Modeling of |
| Fregonara | [11C](R)-Rolipram in Healthy Volunteers and Depressed Subjects | |
| P111 | Miho Shidahara | Wavelet-Based Resolution Recovery Using an Anatomical Prior Provides Quantitative Recovery for Human Population Phantom PET [11C]Raclopride Data |
| P112 | Ryuji Nakao | Rapid Metabolite Analysis of PET Radioligands by Direct Plasma Injection Combining Micellar Cleanup with Fast-Micellar Liquid Chromatography |
| P114 | Vesna Sossi | New Insights into Levodopa Induced Dopamine Release in Parkinson's Disease |
| P115 | Su Jin Kim | lp-ntPET Finds Significant Fast Dopamine Responses to Cigarette Smoking in Sub-Regions of the Striatum |
| P118 | Seongho Seo | Parametric Mapping of [18F]FP-CIT Dynamic PET Based on Graphical Analysis for the Assessment of Abnormal Dopamine Transporter Binding in Parkinson's Disease |
| P120 | Felix Pierre Kuhn | Validation of an Automated Method for Quantitative Evaluation of 11C-Raclopride PET Data Based on a PET-Template |
| P123 | Gaia Rizzo | Evaluation of PET Quantification Sensitivity to the Arterial Input Function Modeling |
| P124 | Martin Schain | Image Derived Input Function Using a Multivariate Analysis Method Based on Pair-Wise Correlation between PET-Image Voxels |
| P129 | My Jonasson | Parametric Methods for [11C]PE2I Positron Emission Tomography |
| P131 | Rajesh Narendran | Imaging Dopamine Transmission in the Prefrontal Cortex: A Combined Microdialysis and [11C]FLB 457 PET Study |
| P132 | Mark Lubberink | Measurement of Absolute Cerebral Blood Flow During Cardiopulmonary Bypass and Selective Cerebral Perfusion Using [15O]Water and PET |
| P133 | Joel T. Dunn | Establishing the Reliability of an Adapted [18F]-Fallypride Imaging Protocol in Healthy Older People |
| P135 | Jean-Dominique Gallezot | Evaluation of Biases Induced by Noise Reduction Algorithms Based on Principal Component Analysis for PET Tracers with Small, High-Contrast Regions of Interest on the HRRT Scanner |
| P136 | Graham Searle | A Molecular Imaging Analysis Pipeline Aimed at Maximising Quality and Throughput |
| P137 | Mika Naganawa | Test-Retest Reproducibility of Kappa Opioid Receptor Binding Assessed with [11C]GR103545 in Humans |
| P138 | Dianne E. Lee | Evaluation of Linear and Nonlinear Spatial Transformation Models for High Resolution PET Studies of Small Brain Structures |
| P140 | Chie Seki | Relationship Between Kinetic Parameters of [11C]PIB and Amyloid β Deposition Studied in Amyloid Precursor Protein Transgenic Mouse Brains |
| P141 | Cristian C. Constantinescu | Preliminary Evaluation of In Vivo NET Binding in the Rat Brain with [11C]Dalene and [11C]TAZA Using PET Imaging |
| P142 | Andri C. Tziortzi | Quantification of Dopamine Release within the Connectivity-Derived Functional Subdivision of Striatum |
| P145 | Mattia Veronese | Optimal Design in PET Occupancy Studies: A Sensitivity Study |
| P146 | Shaonan Wang | Robust Kinetic Model for Quantification of P-glycoprotein (P-gp) Function under Altered Metabolism and after P-gp Inhibition Using (R)-[C-11]Verapamil and PET |
| P147 | Yin Chen | Evaluation of PiB Relative Delivery Value (R1) as a Proxy of Relative Cerebral Blood Flow |
| P150 | Amith Harsha | Development and Validation of an Integrative Software for Automatic MRI and [11C]PiB dynamic PET Image Processing and Parametric Imaging |
| P152 | Marc Normandin | Evaluation of the Performance of a Novel Mobile Brain PET-CT |
| P161 | Yun Zhou | Unbiased Noninvasive Quantification of [11C](+)McN5652 and [11C]MDL100,907 Cerebral Specific Binding in Human Dynamic PET Studies |
| P165 | Olivier Rousset | In Vivo Amyloid Deposition in the Aging Brain: Methodological Considerations for Partial Volume Correction |
| Poster Session III |
||
|---|---|---|
|
|
||
| P005 | Hiroyuki Takuwa | Cerebrovascular Dysfunction during Somatosensory Stimulation Associated with β-Amyloid Accumulation in APP Transgenic Mice |
| P006 | Lauri Tuominen | Studying the Interaction of Neurotransmitter Networks with PET: An Example on Serotonin and Opioid Systems |
| P009 | Bart van Berckel | No Evidence for Additional Blood-Brain Barrier P-glycoprotein Dysfunction in Alzheimer's Disease Patients with Microbleeds |
| P011 | Kristina Simonyan | GABAergic Correlates of Speech Production |
| P020 | Matthew S. Milak | Short-Term SSRI Treatment Reduces 5-HT1A Autoreceptor Binding in the Treatment of Major Depressive Disorder |
| P023 | Rajesh Narendran | An Open-Label Positron Emission Tomography (PET) Study to Evaluate Serotonin Transporter (SERT) Occupancy Following Escalating Doses of Desvenlafaxine (Pristiq®) |
| P026 | Jenny Häggkvist | Test-Retest Variability of [11C]Raclopride in Rat Using PET/MRI |
| P027 | Sjoerd Finnema | Further Validation of the Serotonin Sensitivity of [11C]AZ10419369 Receptor Binding in Non-Human Primates |
| P028 | Miklós Tóth | Visualizing the Central 5-HT1B Receptor with PET in Rats: Effects of Cyclosporin A on [11C]AZ10419369 Uptake |
| P029 | Sjoerd Finnema | Characterization of [11C]CIMBI-36 as a 5-HT2A Receptor Agonist PET Radioligand in the Non-Human Primate Brain |
| P031 | Jim Myers | Sensitivity of the Benzodiazepine Inverse Agonist PET Ligand [11C]Ro15–4513 to Changes in Endogenous GABA |
| P032 | Stefanie Dedeurwaerdere | PET Imaging of Brain Inflammation during Epileptogenesis in the Rat |
| P039 | Markus Savli | Interaction of Inhibitory and Excitatory Receptors of the Serotonergic System: A Multi-Tracer PET Study |
| P044 | Brenda Mc Mahon | Three Weeks of Daily Exposure to Bright Light Does Not Alter Striatal Serotonin Transporter Binding in Healthy Scandinavians |
| P045 | Seong A. Shin | Abnormalities in GABAergic Neurotransmission and Glucose Metabolism in Patients with Essential Tremor in PET Study Using [18F]Flumazenil and [18F]FDG |
| P046 | Danielle Z. Bolling | The Effects of a Serotonin 2C Receptor Agonist on Endogenous and Amphetamine-Induced Dopamine Levels in Rhesus Monkeys |
| P048 | Kenji Ishibashi | Differential Roles of Dopamine D1- and D2-Like Receptors in Impulsivity: A Preliminary PET Study |
| P049 | Dirk Bender | Mannitol Infusion and Blood Brain Barrier Permeability |
| P050 | Daniel Albrecht | Initial Assessment of the Dopamine System in Fibromyalgia |
| P053 | Irina Esterlis | Effect of a Nicotine Vaccine on Nicotine Binding to the Beta2-nAChRs In Vivo in Human Tobacco Smokers |
| P056 | J. John Mann | Serotonin Transporter Promotor Variants Are Not Associated with Transporter Binding in Human Brain: A PET and Postmortem Brain Study |
| P059 | Evan Morris | Occupancy of Naltrexone at Kappa Opioid Receptors May Predict Efficacy in Reducing Drinking in Alcoholics |
| P064 | Hiroto Kuwabara | The Ventral Striatum Shows Initial Preservation of Dopamine Transporters but Indistinguishable Progression Rates of Degeneration in Parkinson's Disease as Measured with [11C]Methylphenidate PET |
|
|
||
| P071 | Michael Honer | Specificity Assessment of the GABAA Receptor α5 Subtype Preferring Radiotracer [3H]RO15-4513 |
| P078 | Antony Gee | Measuring Non-Specific Binding of Novel PET Radioligands to Determine Structure-Activity Relationships between NSB and Their Physiochemical Properties |
| P083 | Edilio Borroni | Characterization of RO5013853, a Novel Positron Emission Tomography Radiotracer for the Imaging of the Glycine Transporter Type 1 |
| P085 | Anton Forsberg | Sensitive and Specific Amyloid-β PET Imaging Using the Three Novel Radioligands [18F]AZD4694, [11C]AZD2184 and [11C]AZD2995 in Alzheimer's Disease Patients |
| P087 | Xavier Langlois | Preclinical Characterization of [11C]JNJ42491293, a PET Tracer for the mGluR2 Positive Allosteric Site |
| P088 | Min-Liang Pan | 11C-TAZA and 11C-Dalene: New PET Imaging Agents for Human Brain Senile Plaques Also Bind to Norepinephrine Transporter |
| P092 | Lisheng Cai | Development of Candidate18F-Labeled PET Imaging Agents for β-Amyloid Plaque in Alzheimer's Disease |
| P093 | Wendol A. Williams | Test-Retest Evaluation of [18F]FPEB, a PET Tracer for the MGluR5 Receptors in Humans |
|
|
||
| P101 | Jun Toyohara | Does σ1 Ligand [11C]SA4503 Bind to the Emopamil Binding Protein in the Brain In Vivo? |
| P104 | Stuart Morton | Building and Utilizing In Silico Tool to Identify Potential Molecules for Evaluation as Preclinical Tracers: Facilitating Rapid Receptor Occupancy Assay Development |
| P105 | Tetsuya Tsujikawa | Quantification of Human Brain Cannabinoid CB1 Receptors Using a Novel PET Radioligand, [11C]SD5024 |
| P106 | Talakad Lohith | Reproducibility Measurements of [11C]NOP-1A, a New PET Radioligand to Image Nociceptin/Orphanin FQ Peptide (NOP) Receptors in Healthy Subjects |
| P116 | Dustin Wooten | 5-HT1A Sex Based Differences in BPND Are Due to KDapp and Not Bmax |
| P121 | Mattia Veronese | Spectral Analysis Iterative Filter for Voxel-Wise Quantification of PET Tracers with Irreversible Uptake |
| P122 | Osama Sabri | Improved Diagnostic Performance of Florbetaben β-Amyloid PET via Partial Volume Effect Correction |
| P125 | Martin Schain | Improved Mapping and Quantification of Serotonin Transporter Availability in the Human Brainstem with the HRRT |
| P126 | Gaia Rizzo | Voxel-Wise Quantification of [11C](R)-Rolipram PET Data in Human Brain |
| P127 | Sophie Holmes | Can Non-Invasive Analysis Detect Group Differences in 5HT2A Receptor Binding Measured Using 11C-MDL100907 PET? |
| P128 | Vanessa Barth | In Vivo Characterization of Binding Potential, Standardized Brain Uptake (SUV), and Brain Kinetics in Rodents by Liquid Chromatography Coupled to Tandem Mass Spectrometry (LCMS/MS) of Non-Labeled Positron Emission Tomography (PET) Imaging Tracers Predicts Translational Imaging Outcomes in Nonhuman Primates and Humans |
| P130 | Christopher Coello | Common Reference Tissue Kinetic Model for Comparison of Three Opioid Receptor Tracers in the Rat Brain |
| P143 | Alexander Hammers | Test-Retest Reliability of [11C]Flumazenil Data Acquired Using the Delforge Partial Saturation Method |
| P144 | Christopher J. Endres | PETmodel: An SPM Toolkit for Parametric Imaging of Dynamic PET Data |
| P149 | Georg Becker | PET Quantification of (−)-[18F]-Flubatine Binding to Nicotinic alpha4beta2 Acetylcholine Receptors in Human Brains |
| P153 | Marc Normandin | A Kinetic Model for Mapping Dopamine Function with Simultaneous PET/MR |
| P155 | Kenji Ishibashi | Is the Cerebellum the Best Reference Region for a PET Study with [F-18]-Fallypride? |
| P156 | Anat Maoz | PK11195-PET Modeling Using a Non-Brain Reference Region |
| P157 | My Jonasson | Effect of Variations in Cerebellum Kinetics on Robustness of [11C]DASB Parametric Images |
| P158 | Robert Koeppe | Kinetic Analysis of [18F]FEOBV, a PET Radiotracer for Imaging the Vesicular Acetylcholine Transporter |
| P160 | Linda Hildegard Bergersen | Lactate Receptor Locations Link Neurotransmission, Neurovascular Coupling, and Brain Energy Metabolism |
| P163 | Qi Guo | Quantification of 18F-PBR111 PET for TSPO Imaging in Humans |
| P164 | Hassan Mohy-ud-Din | Investigation of Noise-Induced Correlations in Dual-Biomarker Parametric Imaging from Dynamic [11C]PiB PET |